Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

484 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Topical therapy is underused in patients with ulcerative colitis.
Seibold F, Fournier N, Beglinger C, Mottet C, Pittet V, Rogler G; Swiss IBD cohort study group. Seibold F, et al. Among authors: beglinger c. J Crohns Colitis. 2014 Jan;8(1):56-63. doi: 10.1016/j.crohns.2013.03.005. Epub 2013 Apr 6. J Crohns Colitis. 2014. PMID: 23566922 Free article.
Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
Schoepfer AM, Beglinger C, Straumann A, Safroneeva E, Romero Y, Armstrong D, Schmidt C, Trummler M, Pittet V, Vavricka SR. Schoepfer AM, et al. Among authors: beglinger c. Inflamm Bowel Dis. 2013 Feb;19(2):332-41. doi: 10.1097/MIB.0b013e3182810066. Inflamm Bowel Dis. 2013. PMID: 23328771 Clinical Trial.
Monitoring of therapy for inflammatory bowel disease.
Burri E, Beglinger C, Lehmann FS. Burri E, et al. Among authors: beglinger c. Digestion. 2012;86 Suppl 1:1-5. doi: 10.1159/000341953. Epub 2012 Oct 5. Digestion. 2012. PMID: 23051719 Review.
484 results